Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Steven Gary DuBois, M.D.

Concepts (480)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neuroblastoma602024125112.110 Why?
3-Iodobenzylguanidine3220231147.060 Why?
Bone Neoplasms46202425316.550 Why?
Antineoplastic Combined Chemotherapy Protocols382024117092.200 Why?
Gene Amplification8202210852.160 Why?
Neoplasms492024220322.000 Why?
Neoplasm Recurrence, Local35202492731.980 Why?
Osteosarcoma1320248971.880 Why?
Antineoplastic Agents372024135911.850 Why?
Radiopharmaceuticals19202326341.740 Why?
Neoplasms, Second Primary10202210561.670 Why?
Child1562024798181.580 Why?
Neuroectodermal Tumors, Primitive, Peripheral42023441.570 Why?
Adrenal Gland Neoplasms720227331.570 Why?
Iodine Radioisotopes12202210321.470 Why?
Radiation-Sensitizing Agents620223451.410 Why?
Child, Preschool972024420621.410 Why?
Vincristine12202310381.390 Why?
Bone Marrow Neoplasms220201011.310 Why?
Medical Oncology16202323121.280 Why?
Infant712024360551.130 Why?
Salvage Therapy7202112681.110 Why?
Adolescent1132024878921.090 Why?
Pyrimidines9202230061.060 Why?
Sarcoma10202317851.060 Why?
Receptor, trkA420201590.980 Why?
Clinical Trials, Phase I as Topic420233260.970 Why?
Norepinephrine Plasma Membrane Transport Proteins42023660.950 Why?
Soft Tissue Neoplasms5202311520.910 Why?
Prognosis422023295570.900 Why?
Paraganglioma220221420.880 Why?
Drug Resistance, Neoplasm11202152490.880 Why?
SEER Program13202015300.860 Why?
Camptothecin320165880.860 Why?
Central Nervous System Neoplasms420219160.810 Why?
Glomus Tumor12022620.780 Why?
Maximum Tolerated Dose1020238760.770 Why?
Humans20920247584060.760 Why?
Clinical Trials as Topic12202479850.760 Why?
Indenes12021580.750 Why?
Vesicular Monoamine Transport Proteins22023320.740 Why?
Pathology, Molecular220213280.730 Why?
Polycythemia120211250.730 Why?
Clinical Trials, Phase II as Topic320206270.720 Why?
Young Adult632024588080.710 Why?
Minors12020580.700 Why?
Calmodulin-Binding Proteins220112320.680 Why?
Gene Fusion220193540.680 Why?
Neoplasms, Unknown Primary120201020.680 Why?
Off-Label Use220241850.680 Why?
Age Factors162020183580.630 Why?
Disease-Free Survival14202368210.620 Why?
Radionuclide Imaging5202219750.610 Why?
Oncogene Proteins, Fusion10202315940.600 Why?
Industry120203610.600 Why?
Amyloid Precursor Protein Secretases120226200.600 Why?
Pelvic Neoplasms220222480.590 Why?
Azepines220183290.590 Why?
Kaplan-Meier Estimate14201864930.590 Why?
Ganglioneuroma12017530.570 Why?
Ifosfamide720232320.570 Why?
Male10920243587470.560 Why?
Pyrazoles5202219880.550 Why?
Oncogene Proteins420157190.550 Why?
Hydroxamic Acids320154810.550 Why?
Pyrroles4202111300.550 Why?
Thoracic Neoplasms220192660.540 Why?
Benzazepines120183100.540 Why?
Etoposide720236300.540 Why?
Research Support as Topic220206970.540 Why?
Survival Rate162023127210.540 Why?
Wilms Tumor320153750.510 Why?
Female10920243903230.510 Why?
Neoplasm Staging152022111520.510 Why?
Basic Helix-Loop-Helix Transcription Factors1202111360.510 Why?
Carcinoma, Neuroendocrine120193460.500 Why?
Neoplasms, Radiation-Induced120195460.500 Why?
Molecular Targeted Therapy10202227960.490 Why?
Bone Marrow5202029090.480 Why?
Indoles4202118280.480 Why?
Cyclophosphamide6202322180.470 Why?
Radiotherapy3201915040.470 Why?
Protein Kinase Inhibitors11202456290.460 Why?
Adult6820232199350.460 Why?
Infant, Newborn232022261830.450 Why?
Neoplastic Cells, Circulating220119380.440 Why?
Dysostoses1201270.430 Why?
Nuclear Proteins8202357860.430 Why?
Doxorubicin8202322090.420 Why?
Neoplasms, Multiple Primary120175860.420 Why?
Dacarbazine120165590.420 Why?
Gene Dosage1201712180.420 Why?
Annexin A5120121030.410 Why?
Chromosome Aberrations5202217630.410 Why?
Treatment Outcome302021643780.400 Why?
RNA-Binding Proteins2201118940.400 Why?
Neoplasm Metastasis9201949010.390 Why?
Follow-Up Studies232024390590.390 Why?
Retrospective Studies402024801680.380 Why?
Histones3201825770.370 Why?
Combined Modality Therapy14202285300.360 Why?
Neovascularization, Pathologic3201426380.360 Why?
Carcinoma5202223300.360 Why?
Gastrointestinal Stromal Tumors320216150.360 Why?
RNA-Binding Protein EWS320212100.340 Why?
Topotecan220211320.330 Why?
Cohort Studies182020412560.330 Why?
Sirolimus4201715330.320 Why?
Mortality1202028860.320 Why?
Proportional Hazards Models72017124400.320 Why?
United States Food and Drug Administration7202316590.320 Why?
Introns120119780.310 Why?
Hematopoietic Stem Cell Transplantation5202256490.310 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma5202015470.290 Why?
United States242024721360.290 Why?
Translocation, Genetic3202113870.290 Why?
Biomedical Research2202034180.290 Why?
Kidney Neoplasms6201743120.290 Why?
Neoplasm Proteins2202136090.280 Why?
Tissue Distribution5202122620.280 Why?
Cytarabine120096960.280 Why?
Glioma4202434180.280 Why?
Loss of Heterozygosity320196590.280 Why?
Pregnancy Complications, Neoplastic120082550.260 Why?
Databases, Factual4201879800.260 Why?
Thyroid Neoplasms1201923320.260 Why?
Fibrosarcoma220183080.260 Why?
Drug Administration Schedule6202048390.260 Why?
Gene Expression Regulation, Neoplastic6202285060.260 Why?
Neoadjuvant Therapy5202228210.260 Why?
Pheochromocytoma220223280.260 Why?
Drug Approval420238080.260 Why?
Drug Dosage Calculations320201170.250 Why?
Lymphocyte Count120077780.240 Why?
Gastrointestinal Neoplasms320219510.230 Why?
Gene Frequency1201136120.230 Why?
Ferritins220195970.230 Why?
Angiogenesis Inhibitors2201420470.230 Why?
Dose-Response Relationship, Drug82023107480.220 Why?
Time Factors122022398720.220 Why?
Logistic Models42022132760.220 Why?
Flow Cytometry3201158640.220 Why?
Adenocarcinoma1202063130.210 Why?
Sarcoma, Small Cell12023170.210 Why?
Antibodies, Monoclonal5202391600.210 Why?
Rhabdomyosarcoma, Alveolar12023420.210 Why?
Receptor Protein-Tyrosine Kinases3202216130.210 Why?
Radiometry420168130.210 Why?
Radiotherapy Dosage5202428960.210 Why?
Poverty2202426920.200 Why?
Neutropenia320178840.200 Why?
Normetanephrine12021250.200 Why?
Brain Neoplasms7202289810.200 Why?
Leukemia, Lymphoid120023100.200 Why?
Proteins3202160260.190 Why?
Lymph Nodes1201334850.190 Why?
Whole-Body Irradiation320164330.190 Why?
Granuloma, Plasma Cell12022800.190 Why?
Survival Analysis72020101120.190 Why?
Neoplasms, Muscle Tissue12021670.190 Why?
Histone Deacetylase Inhibitors320187720.190 Why?
Genomics7202257900.190 Why?
Chromogranins120211610.190 Why?
Rhabdomyosarcoma220233580.190 Why?
Tumor Suppressor Protein p533201929120.180 Why?
Cell Cycle Proteins4202234420.180 Why?
Chi-Square Distribution2202034250.180 Why?
L-Lactate Dehydrogenase220144100.180 Why?
Registries2202081750.180 Why?
Drug Monitoring220189600.180 Why?
Protein-Tyrosine Kinases3202224160.180 Why?
Lymphoma2201918960.180 Why?
Alleles1201168950.170 Why?
Head and Neck Neoplasms1201428820.170 Why?
Cell Line, Tumor52022168860.170 Why?
Indole Alkaloids12019230.170 Why?
Diketopiperazines12019240.170 Why?
Drug Industry320217870.170 Why?
DNA Glycosylases120201240.170 Why?
High-Throughput Nucleotide Sequencing3202236150.170 Why?
Research Subjects120212490.170 Why?
Prenylation12019370.170 Why?
Mutation92020299150.170 Why?
Disease Progression82024134680.170 Why?
Healthcare Disparities2202433640.170 Why?
Receptor, Notch1120224950.160 Why?
Fluorodeoxyglucose F183202220040.160 Why?
Government120201610.160 Why?
In Situ Hybridization, Fluorescence3202125040.160 Why?
Standard of Care120235500.160 Why?
Adrenal Glands120215540.160 Why?
Prospective Studies112023541370.160 Why?
Neoplasms, Connective and Soft Tissue12019340.160 Why?
Nomograms120202370.160 Why?
TOR Serine-Threonine Kinases3202420570.160 Why?
Risk Factors122020738090.160 Why?
Genomic Structural Variation12018630.160 Why?
Calcitonin120193300.150 Why?
Carbazoles120192200.150 Why?
Endothelial Cells1201135330.150 Why?
Ribonuclease III120202790.150 Why?
Germ-Line Mutation4202018400.150 Why?
Nephroma, Mesoblastic12017240.150 Why?
Lung Neoplasms52023132450.150 Why?
Stem Cells1201135210.150 Why?
Legislation, Drug120202140.150 Why?
Academies and Institutes120203190.150 Why?
Jumonji Domain-Containing Histone Demethylases120181710.150 Why?
Signal Transduction32024233420.140 Why?
Blood Pressure1201384510.140 Why?
Research Design3202361570.140 Why?
Cancer Care Facilities120204240.140 Why?
Recurrence7202284260.140 Why?
Gene Expression Profiling3201994040.140 Why?
DEAD-box RNA Helicases120203830.140 Why?
Technetium Tc 99m Medronate120171310.140 Why?
Administration, Oral4202039910.140 Why?
Retreatment120185960.140 Why?
Microtubule-Associated Proteins2202210740.140 Why?
Genetic Heterogeneity120207230.140 Why?
Leukemia2201615190.140 Why?
National Institutes of Health (U.S.)120207910.130 Why?
Antibiotics, Antineoplastic220176750.130 Why?
Survivors3201623700.130 Why?
Leukemia, Myeloid120196950.130 Why?
Proto-Oncogene Proteins c-bcl-21202214040.130 Why?
Risk3201995990.130 Why?
Pediatrics6202135870.130 Why?
Vascular Endothelial Growth Factor A1200734800.130 Why?
Models, Biological3202194600.130 Why?
Tongue Neoplasms120171830.130 Why?
Health Services Accessibility1201354040.130 Why?
Drug Discovery2202010440.130 Why?
Tablets120161470.130 Why?
Histone Deacetylases220187180.130 Why?
Proto-Oncogene Proteins c-akt1202424430.130 Why?
Glucuronosyltransferase120161300.130 Why?
Proto-Oncogene Proteins3202344850.130 Why?
Blood Sedimentation120162340.130 Why?
Syndrome1202132620.120 Why?
Pelvic Bones120172700.120 Why?
Neoplasm, Residual1202010070.120 Why?
Tumor Burden4201918930.120 Why?
Rhabdoid Tumor120172100.120 Why?
Acetylation2201510600.120 Why?
Molecular Diagnostic Techniques120196110.120 Why?
Lymphatic Metastasis2201329430.120 Why?
Polymorphism, Single Nucleotide32019157730.120 Why?
Dose-Response Relationship, Radiation420208810.120 Why?
Transplantation, Autologous4202121140.120 Why?
Antibodies, Bispecific120161910.110 Why?
Pyridazines120152000.110 Why?
Mitosis1201911910.110 Why?
Cytoskeletal Proteins1201913420.110 Why?
Purines120176050.110 Why?
Receptor, IGF Type 1120163800.110 Why?
Paraffin Embedding120143020.110 Why?
Genetic Engineering120199330.110 Why?
Cyclin-Dependent Kinase 4120175550.110 Why?
Aminopyridines120175640.110 Why?
Cisplatin3202216450.110 Why?
Incidence62020212720.110 Why?
Nifedipine120132210.100 Why?
International Cooperation2202114300.100 Why?
Killer Cells, Natural1200222010.100 Why?
Growth Plate120142740.100 Why?
Immunologic Factors1202215850.100 Why?
Biological Products120229060.100 Why?
Serine Endopeptidases1201710200.100 Why?
Middle Aged1920232195680.100 Why?
Models, Animal1201821120.100 Why?
Powders12011790.100 Why?
Extremities120178650.100 Why?
Pyrrolidinones120121160.100 Why?
Multivariate Analysis32014120960.100 Why?
Genome1202017390.100 Why?
Aged, 80 and over82023586830.090 Why?
Randomized Controlled Trials as Topic22021101460.090 Why?
Dexmedetomidine120153160.090 Why?
Age Distribution1201728820.090 Why?
Piperidines1201916390.090 Why?
Radiosurgery1202013420.090 Why?
Melanoma2201956910.090 Why?
Genetic Association Studies1202027170.090 Why?
Telangiectasis12010770.090 Why?
Microphthalmia-Associated Transcription Factor120122590.090 Why?
Neuroectodermal Tumors, Primitive120111360.090 Why?
Forecasting1201929230.090 Why?
Antigens, CD2201139970.080 Why?
NF-kappa B1201824720.080 Why?
Risk Assessment42020238840.080 Why?
Proteinuria120125940.080 Why?
Li-Fraumeni Syndrome120101170.080 Why?
Aged1320231682180.080 Why?
Dactinomycin120093040.080 Why?
Vasodilator Agents120139730.080 Why?
Biopsy1202067680.080 Why?
Chronic Disease1202392670.080 Why?
Gene Expression2201875830.080 Why?
DNA Damage1201824390.080 Why?
Proto-Oncogene Proteins c-met120125670.080 Why?
Stem Cell Transplantation2201615990.080 Why?
Lipoma120102920.080 Why?
Fibromatosis, Aggressive120091250.080 Why?
Magnetic Resonance Imaging42021362840.070 Why?
Statistics, Nonparametric3202028500.070 Why?
Proto-Oncogene Proteins c-mdm2120103670.070 Why?
Hypnotics and Sedatives1201511760.070 Why?
Pilot Projects2202085530.070 Why?
Epigenesis, Genetic1202137540.070 Why?
Liposarcoma120102830.070 Why?
Boston1202093040.070 Why?
Mass Spectrometry1201421890.070 Why?
Linear Models1201758620.070 Why?
Intensive Care Units, Pediatric1201410140.070 Why?
Escherichia coli1201942150.070 Why?
Tomography, X-Ray Computed42022205000.070 Why?
Quinolines120127590.070 Why?
Busulfan220212580.070 Why?
Immunotherapy1202246410.070 Why?
Boronic Acids120109140.070 Why?
Immunohistochemistry32015110700.070 Why?
Drug Utilization1201211870.060 Why?
Melphalan220214200.060 Why?
Models, Statistical1202050700.060 Why?
Cross-Sectional Studies32022259560.060 Why?
Upper Extremity120106610.060 Why?
Chemotherapy, Adjuvant1201335270.060 Why?
Carcinoma, Small Cell120074160.060 Why?
Leukemia, Myeloid, Acute2201735990.060 Why?
Anti-Infective Agents120129810.060 Why?
Acute Disease2201372250.060 Why?
Genotype22016129450.060 Why?
Pyrazines1201011980.060 Why?
Asparaginase220202400.060 Why?
Granulocyte Colony-Stimulating Factor120076290.060 Why?
Receptors, Progesterone1200811300.060 Why?
Positron-Emission Tomography2202264570.060 Why?
Cell Adhesion Molecules1201016000.060 Why?
Drug Evaluation, Preclinical2202013350.050 Why?
Mice, Nude3201836020.050 Why?
Consensus2202430990.050 Why?
Cyclin B120231040.050 Why?
Hospitals, Pediatric1201218540.050 Why?
Case-Control Studies22011220290.050 Why?
Plasma Cell Granuloma, Pulmonary12021120.050 Why?
Phenotype22020165340.050 Why?
Carcinoma, Squamous Cell1201740230.050 Why?
Hearing Loss120097800.050 Why?
Academic Medical Centers1201227510.050 Why?
Animals820201677680.050 Why?
Infusions, Intravenous2201622100.050 Why?
Sacrum120222770.050 Why?
European Union120211570.050 Why?
Clinical Protocols2201614360.040 Why?
Desmoplastic Small Round Cell Tumor12020330.040 Why?
Hospital Mortality1201452720.040 Why?
Nucleotides120234500.040 Why?
Genetic Predisposition to Disease42021177680.040 Why?
Receptors, Estrogen1200822100.040 Why?
Bone and Bones1201125600.040 Why?
Membrane Proteins1201778430.040 Why?
Sequence Analysis, RNA2201820010.040 Why?
Tanzania2201513830.040 Why?
Mitoxantrone120201480.040 Why?
Cytochrome P-450 CYP3A120201140.040 Why?
Drug and Narcotic Control120201450.040 Why?
Socioeconomic Factors1201378180.040 Why?
Repressor Proteins2202329800.040 Why?
Therapies, Investigational120201110.040 Why?
Predictive Value of Tests12015152250.040 Why?
Carrier Proteins1201249380.040 Why?
Xenograft Model Antitumor Assays2201835740.040 Why?
Granulocyte-Macrophage Colony-Stimulating Factor120228860.040 Why?
Dexamethasone2202019270.040 Why?
Radiation Dosage2202019560.040 Why?
Health Status Disparities1201018310.040 Why?
Heart1201143820.040 Why?
Radiography1200969540.040 Why?
Arabinonucleosides12017340.040 Why?
Adenine Nucleotides120171110.040 Why?
Drug Labeling120202480.040 Why?
Annual Reports as Topic12017360.040 Why?
Gene Expression Regulation12015118920.040 Why?
Receptor, trkB120181250.040 Why?
Oncogenes1202212200.030 Why?
Isotretinoin120181320.030 Why?
Proto-Oncogene Proteins c-ets120173110.030 Why?
Chromosomes, Human, Pair 19120173470.030 Why?
Fatal Outcome2201218290.030 Why?
Thrombocytopenia1200411710.030 Why?
Rare Diseases120216190.030 Why?
Chromosomes, Human, Pair 15120173620.030 Why?
Germany120188680.030 Why?
Congresses as Topic120207990.030 Why?
Benzothiazoles120162460.030 Why?
Morpholines120185800.030 Why?
Confidence Intervals1202029250.030 Why?
Stomatitis120162710.030 Why?
Genetic Testing2201735300.030 Why?
Polyethylene Glycols1202011890.030 Why?
Disease Susceptibility1202017880.030 Why?
Proto-Oncogene Proteins c-myc119999890.030 Why?
Blotting, Western2201150310.030 Why?
Europe1202034200.030 Why?
Organ Specificity1201819550.030 Why?
Radiation Injuries1202011820.030 Why?
Hypertension1201384990.030 Why?
Single-Blind Method1201615700.030 Why?
Phenylurea Compounds120165290.030 Why?
Metanephrine12012250.030 Why?
Compassionate Use Trials12012500.030 Why?
Sarcoma, Alveolar Soft Part12012430.030 Why?
fms-Like Tyrosine Kinase 3120164950.030 Why?
Glucocorticoids1202121440.030 Why?
Reverse Transcriptase Polymerase Chain Reaction2201145670.020 Why?
Sarcoma, Clear Cell12012720.020 Why?
Minnesota120123380.020 Why?
Base Sequence12022124360.020 Why?
Tumor Stem Cell Assay120111150.020 Why?
Chemistry, Pharmaceutical120122750.020 Why?
Treatment Failure1201726400.020 Why?
Conscious Sedation120155290.020 Why?
Regression Analysis1202063540.020 Why?
Cephalosporins120122040.020 Why?
California1201514190.020 Why?
Drug Utilization Review120122480.020 Why?
Protein Kinases1201816100.020 Why?
Epigenomics120169360.020 Why?
Gamma Rays120113170.020 Why?
DNA Copy Number Variations1201820120.020 Why?
Monte Carlo Method1201512560.020 Why?
Software2201544150.020 Why?
Inappropriate Prescribing120122090.020 Why?
Age of Onset1201632980.020 Why?
DNA Repair Enzymes120113440.020 Why?
Multicenter Studies as Topic1201417050.020 Why?
Methotrexate1201617190.020 Why?
DNA Repair1201820380.020 Why?
Vancomycin120125030.020 Why?
Luminescent Proteins120118350.020 Why?
Mice42018811010.020 Why?
Health Policy1202026770.020 Why?
Sequence Analysis, DNA1201847110.020 Why?
Membrane Glycoproteins1201837050.020 Why?
Protease Inhibitors120107540.020 Why?
Pregnancy12008297420.020 Why?
Prevalence12023156510.020 Why?
Diagnosis, Differential12021129510.020 Why?
Myelodysplastic Syndromes1201613920.020 Why?
Computer Simulation1202062010.020 Why?
Neoplasms, Experimental1201112280.020 Why?
Radiography, Thoracic1201212960.020 Why?
Family Health1201012570.020 Why?
Microscopy, Electron, Transmission120076950.020 Why?
Prescription Drugs120126260.010 Why?
Societies, Medical1201738910.010 Why?
Hematologic Neoplasms1201618900.010 Why?
Staining and Labeling1200810830.010 Why?
Pancreatic Neoplasms1202153490.010 Why?
Contrast Media1201752980.010 Why?
Forkhead Transcription Factors1201116110.010 Why?
Tumor Cells, Cultured1201161270.010 Why?
Developing Countries1201528660.010 Why?
Transplantation, Heterologous1201123780.010 Why?
Imaging, Three-Dimensional1201640480.010 Why?
Transcription Factors12022120940.010 Why?
Parents1201635480.010 Why?
Early Detection of Cancer1201732110.010 Why?
Pedigree1201045780.010 Why?
Inflammation12021107180.010 Why?
HEK293 Cells1201142570.010 Why?
RNA, Messenger12016127590.010 Why?
Cell Survival1201157810.010 Why?
Comorbidity12014104950.010 Why?
Carcinoma, Renal Cell1201232170.010 Why?
Cell Proliferation12011104160.010 Why?
Apoptosis1201194680.010 Why?
Quality of Life12012132850.010 Why?
Breast Neoplasms12017210170.010 Why?
DuBois's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (480)
Explore
_
Co-Authors (123)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.